Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis

Marti, Christophe; Grosgurin, Olivier; Harbarth, Stéphan Juergen; Combescure, Christophe; Abbas, Mohamed; Rutschmann, Olivier Thierry; Perrier, Arnaud; Garin, Nicolas

doi:10.1371/journal.pone.0144032

Scientific article

English

Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis

ContributorsMarti, Christophe; Grosgurin, Olivier; Harbarth, Stéphan Juergen

; Combescure, Christophe

; Abbas, Mohamed; Rutschmann, Olivier Thierry; Perrier, Arnaud; Garin, Nicolas

Published inPloS one, vol. 10, no. 12, e0144032

Publication date2015

Abstract

Community-acquired pneumonia (CAP) induces lung and systemic inflammation, leading to high morbidity and mortality. We systematically reviewed the risks and benefits of adjunctive corticotherapy in the management of patients with CAP.

Keywords

Adrenal Cortex Hormones/adverse effects/therapeutic use
Communicable Diseases/drug therapy/mortality
Female
Gastrointestinal Hemorrhage/chemically induced/mortality
Humans
Hyperglycemia/chemically induced/mortality
Length of Stay
Male
Pneumonia/drug therapy/mortality
Severity of Illness Index

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département de médecine

Research groups

Citation (ISO format)

MARTI, Christophe et al. Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis. In: PloS one, 2015, vol. 10, n° 12, p. e0144032. doi: 10.1371/journal.pone.0144032

Article (Published version)

CC BY

Identifiers

PID : unige:87631
DOI : 10.1371/journal.pone.0144032
PMID : 26641253

Journal ISSN1932-6203

644views

518downloads

Creation29/08/2016 08:43:00

First validation29/08/2016 08:43:00

Update08/10/2024 09:15:12

Status update08/10/2024 09:15:12

Last indexation31/10/2024 04:34:21

Archive ouverte UNIGE

Adjunctive Corticotherapy for Community Acquired Pneumonia: A Systematic Review and Meta-Analysis

Community-acquired pneumonia (CAP) induces lung and systemic inflammation, leading to high morbidity and mortality. We systematically reviewed the risks and benefits of adjunctive corticotherapy in the management of patients with CAP.

Technical informations